In this analysis, outcomes were investigated among 41 pediatric and young adult patients who had soft-tissue sarcoma and were aged 0 months to 22 years. Among the overall patient population, the most ...
Rashmi Chugh, MD, of the University of Michigan, outlines a strategic roadmap for the future development of ozekibart in ...
Largescale changes in the genome inherited from parents are significant risk factors for pediatric solid tumors, such as Ewing sarcoma, neuroblastoma, and osteosarcoma, according to a new study. The ...
A research team at the Seville Biomedical Institute (IBis) has identified a new molecular mechanism that explains the high sensitivity of Ewing sarcoma (an aggressive bone cancer that mainly affects ...
Researchers developed a therapy targeting IL1RAP, a protein expressed on cancer cells. The target destroyed tumors, reduced ...
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials Ewing Sarcoma (ES), a rare cancer with a pathognomonic translocation resulting in ...
Ewing sarcoma is a tumor of the bones and soft tissues that occurs in children and young people. Like all childhood cancers, it is rare – 9 to 10 cases per million inhabitants per year – but it is ...
The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital have once again teamed up to support a new class of pediatric cancer research fellows. The awards, totaling a $1.5 ...
Asharq Al-Awsat on MSN
New treatment brings hope to children with cancer
Researchers at the University of British Columbia (UBC) Faculty of Medicine in Canada have developed a new targeted cancer therapy that can precisely seek out and destroy tumor cells, showing strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results